Breaking News Instant updates and real-time market news.

PRTK

Paratek Pharmaceuticals

$24.95

0.9 (3.74%)

06:59
07/18/17
07/18
06:59
07/18/17
06:59

Paratek Pharmaceuticals price target raised to $43 from $36 at H.C. Wainwright

H.C. Wainwright analyst Ed Arce raised his price target for Paratek Pharmaceuticals to $43 after the company announced positive top-line results of its alloral Phase 3 trial of omadacycline for the treatment of acute bacterial skin and skin structure infections. The analyst sees higher rates of nausea and vomiting as having a negligible impact to omadacycline's commercial opportunity. He keeps a Buy rating on Paratek shares.

  • 26

    Sep

PRTK Paratek Pharmaceuticals
$24.95

0.9 (3.74%)

04/11/17
HCWC
04/11/17
NO CHANGE
Target $36
HCWC
Buy
Paratek price target raised to $36 from $33 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Paratek Pharmaceuticals to $36 saying omadacycline last week meet a high bar in the treatment of community-acquired bacterial pneumonia. The analyst now has increased confidence in the likelihood of Paratek realizing the drug's blockbuster potential. He keeps a Buy rating on the shares.
05/18/17
RAJA
05/18/17
INITIATION
Target $36
RAJA
Strong Buy
Paratek Pharmaceuticals initiated with a Strong Buy at Raymond James
aymond James analyst Laura Chico initiated Paratek Pharmaceuticals with a Strong Buy and a $36 price target saying omadacycline's "triple threat" potential of pneumonia, skin infections, and urinary tract, combined with management's positioning in recurrent infections and physician familiarity with tetracyclines, creates a favorable position.
06/15/17
06/15/17
NO CHANGE

Leerink 'positively inclined' ahead of Paratek data
Leerink analyst Paul Matteis says his analysis makes him optimistic that rallying 10%-20% is the most probable outcome from Paratek Pharmaceuticals' oral-only phase III skin infection results in mid-July. The company's "strong understanding" of Omadacycline pharmacokinetics, "robust efficacy" at the test-of-cure endpoint in two prior Phase IIIs and the "longstanding efficacy" of tetracyclines in skin support a "high odds of success" for the study, Matteis tells investors in a research note. The analyst reiterates an Outperform rating on Paratek with a $37 price target.
06/22/17
CANT
06/22/17
INITIATION
CANT
Overweight
Paratek Pharmaceuticals coverage assumed with an Overweight at Cantor
Cantor started coverage of Paratek with a $50 price target and an Overweight rating. The analyst recommends buying the stock ahead of what he believes will be positive data for its Omadacycline drug due out in July. The analyst thinks that the trial could show that the drug can be effectively administered through an oral-only indication for skin, differentiating it and enabling it to generate revenue that exceeds expectations.

TODAY'S FREE FLY STORIES

10:25
07/20/17
07/20
10:25
07/20/17
10:25
General news
U.S. leading economic index rose 0.6% to 127.8 in June »

U.S. leading economic…

C

Citi

$66.79

0.09 (0.13%)

10:25
07/20/17
07/20
10:25
07/20/17
10:25
Conference/Events
Citigroup to hold a conference call »

CFO Gerspach holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 25

    Jul

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:21
07/20/17
07/20
10:21
07/20/17
10:21
Hot Stocks
Breaking Hot Stocks news story on Steel Dynamics »

Steel Dynamics CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

TSLA

Tesla

$325.26

-2.98 (-0.91%)

10:21
07/20/17
07/20
10:21
07/20/17
10:21
Hot Stocks
Citi awaits better Tesla entry point as bulls, bears both make good points »

Citi analyst Itay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

VRTX

Vertex

$159.69

27.53 (20.83%)

10:20
07/20/17
07/20
10:20
07/20/17
10:20
Options
Large call spread in Vertex Pharm after yesterday's surge »

Large call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

10:20
07/20/17
07/20
10:20
07/20/17
10:20
General news
Treasury Action: longer yields rotated lower again »

Treasury Action: longer…

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:19
07/20/17
07/20
10:19
07/20/17
10:19
Hot Stocks
Breaking Hot Stocks news story on Steel Dynamics »

Steel Dynamics cites…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

TSLA

Tesla

$325.26

-2.98 (-0.91%)

, JNJ

Johnson & Johnson

$136.03

0.82 (0.61%)

10:19
07/20/17
07/20
10:19
07/20/17
10:19
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

TSLA

Tesla

$325.26

-2.98 (-0.91%)

JNJ

Johnson & Johnson

$136.03

0.82 (0.61%)

TTS

Tile Shop

$14.83

-0.175 (-1.17%)

SBPH

Spring Bank Pharmaceuticals

$14.20

-0.12 (-0.84%)

DISCA

Discovery

$27.18

1.13 (4.34%)

SNI

Scripps Networks

$76.89

9.87 (14.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 09

    Aug

  • 09

    Aug

  • 02

    Oct

PFE

Pfizer

, RAD

Rite Aid

$2.50

-0.1322 (-5.03%)

10:19
07/20/17
07/20
10:19
07/20/17
10:19
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

PFE

Pfizer

RAD

Rite Aid

$2.50

-0.1322 (-5.03%)

FMSA

Fairmount Santrol

$3.63

-0.245 (-6.33%)

NEWR

New Relic

$47.96

-0.84 (-1.72%)

SND

Smart Sand

$7.87

0.25 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 02

    Aug

  • 03

    Aug

  • 03

    Aug

  • 03

    Aug

  • 08

    Aug

  • 27

    Aug

  • 29

    Aug

NKE

Nike

$59.31

1.54 (2.67%)

, BGS

B&G Foods

$37.08

1.275 (3.56%)

10:18
07/20/17
07/20
10:18
07/20/17
10:18
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

NKE

Nike

$59.31

1.54 (2.67%)

BGS

B&G Foods

$37.08

1.275 (3.56%)

HPQ

HP Inc.

$18.86

0.155 (0.83%)

RCL

Royal Caribbean

$115.14

2.5775 (2.29%)

BWLD

Buffalo Wild Wings

$122.60

0.65 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

  • 29

    Aug

  • 11

    Sep

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:18
07/20/17
07/20
10:18
07/20/17
10:18
Hot Stocks
Steel Dynamics sees more stabilized scrap environment in 2H »

Comments from Q2 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

$NSD

NASDAQ Market Internals

10:17
07/20/17
07/20
10:17
07/20/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
07/20/17
07/20
10:16
07/20/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
07/20/17
07/20
10:15
07/20/17
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

10:15
07/20/17
07/20
10:15
07/20/17
10:15
General news
Breaking General news story  »

Week of 7/14 EIA Natural…

RAD

Rite Aid

$2.50

-0.129 (-4.90%)

10:11
07/20/17
07/20
10:11
07/20/17
10:11
Hot Stocks
Rite Aid expands Naloxone dispensing program to Michigan, South Carolina »

Rite Aid announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Hot Stocks
Breaking Hot Stocks news story on Berkshire Hills Bancorp »

Berkshire Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

AMZN

Amazon.com

$1,026.87

2.42 (0.24%)

, GOOG

Alphabet

$970.89

5.49 (0.57%)

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Periodicals
AWS weighs new cloud service based on popular Google software, Information says »

Amazon Web Services…

AMZN

Amazon.com

$1,026.87

2.42 (0.24%)

GOOG

Alphabet

$970.89

5.49 (0.57%)

GOOGL

Alphabet Class A

$992.77

5.82 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 24

    Jul

  • 27

    Jul

TMST

TimkenSteel

$16.00

-0.18 (-1.11%)

, STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Recommendations
TimkenSteel, Steel Dynamics, AK Steel, U.S. Steel, Nucor analyst commentary  »

Cowen would be buying…

TMST

TimkenSteel

$16.00

-0.18 (-1.11%)

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

AKS

AK Steel

$6.52

-0.08 (-1.21%)

X

U.S. Steel

$24.11

-0.36 (-1.47%)

NUE

Nucor

$59.14

-1.52 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 25

    Jul

  • 26

    Jul

  • 01

    Aug

XBI

SPDR S&P BIOTECH

$79.80

0.69 (0.87%)

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Options
Defensive option play in the SPDR Biotech ETF »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

$36.60

0.1 (0.27%)

10:09
07/20/17
07/20
10:09
07/20/17
10:09
Earnings
Berkshire Hills Bancorp sees Q3 core EPS 58c, consensus 57c »

Sees total annualized…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

IRWD

Ironwood

$18.55

-0.23 (-1.22%)

10:07
07/20/17
07/20
10:07
07/20/17
10:07
Recommendations
Ironwood analyst commentary  »

Ironwood weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$31.29

-0.21 (-0.67%)

10:07
07/20/17
07/20
10:07
07/20/17
10:07
Technical Analysis
Technical View: Twilio spikes higher on unconfirmed takeover rumors »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

10:07
07/20/17
07/20
10:07
07/20/17
10:07
General news
Leading Indicators data reported »

June Leading Indicators…

JD

JD.com

$43.22

0.23 (0.54%)

10:05
07/20/17
07/20
10:05
07/20/17
10:05
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.